Science innovation is systematically misjudged when evaluated through startup and software logic. This article explains why science ventures are a distinct category with different timelines, risks, and capital dynamics, and how misclassification distorts metrics, incentives, and investment decisions. It outlines the hidden economic cost of applying startup frameworks to scientific innovation and why correct categorization is the foundation for sound investment, policy, and ve